Universal No-Cost Coverage for Mifegymiso in British Columbia
Starting January 15th BC will cover a drug combination of Mifepristone and Misoprostol for abortions. The provincial government will soon be providing universal, no-cost coverage for the drug Mifegymiso. Universal, no-cost coverage will commence Jan. 15, 2018.
Understanding Mifegymiso and its Application
Mifegymiso, an alternative to surgical abortion, is a combination of the drugs mifepristone and misoprostol. In April 2017, the common drug review recommended Mifegymiso, also known as RU-486, for public coverage. It can be used to terminate pregnancies at an early stage - up to nine weeks from the start of the last menstrual period.
Coverage History and Financial Accessibility
Since July 11, 2017, PharmaCare has been covering Mifegymiso, subject to the rules of a person's PharmaCare plan. However, patients under the Fair PharmaCare plan may face an out-of-pocket expense. Currently, the out-of-pocket cost for Mifegymiso for individuals without PharmaCare coverage is approximately $300. Removing the cost barrier helps ensure that individuals can access this safe, legal and available option if they choose.
Requirements for Patients and Health-Care Professionals
Pharmacists are able to dispense Mifegymiso to patients with a valid prescription. To obtain a prescription, patients must visit a physician or nurse practitioner for an ultrasound to confirm that they do not have an ectopic pregnancy, which is when the pregnancy occurs outside of the uterus. Additionally, health-care professionals who are going to prescribe or dispense Mifegymiso are encouraged to complete an education program.
Pharmacy Availability and Distribution
- Mifegymiso will be available at all participating pharmacies throughout B.C.
- All pharmacies will be able to order the drug as needed, which could take up to two business days to receive.
- Stock of Mifegymiso will be available at pharmacies that are rural, remote or have previously dispensed high volumes of the medication.